Whenever a market leader company in a bullish sector is hammered due to some regulatory issues and if those issues are not too serious and of routine nature it gives a great opportunity to buy.
One such opportunity was presented just 2-3 days back when US FDA conducted surprise inspection of Sun Pharma, it was hammered down but as the issues were not serious, it bounced back giving a good place to buy.
ST